HUP0001940A2 - Benzizotiazolszármazékok, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények - Google Patents

Benzizotiazolszármazékok, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények

Info

Publication number
HUP0001940A2
HUP0001940A2 HU0001940A HUP0001940A HUP0001940A2 HU P0001940 A2 HUP0001940 A2 HU P0001940A2 HU 0001940 A HU0001940 A HU 0001940A HU P0001940 A HUP0001940 A HU P0001940A HU P0001940 A2 HUP0001940 A2 HU P0001940A2
Authority
HU
Hungary
Prior art keywords
cr8r8
alkenyl
nr4r5
alkoxy
group
Prior art date
Application number
HU0001940A
Other languages
English (en)
Inventor
Hong Nie
Melvin Clarence Rutledge
Katherine L. Widdowson
Original Assignee
Smithkline Beecham Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corporation filed Critical Smithkline Beecham Corporation
Publication of HUP0001940A2 publication Critical patent/HUP0001940A2/hu
Publication of HUP0001940A3 publication Critical patent/HUP0001940A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D275/06—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

A találmány (I) általános képletű vegyületekre - amelyek képletében R-NH-C(X2)-NH-(CR13R14)v-Z csoport; X oxigénatom, karbonil-, C(X1)2vagy S(O)m csoport; A jelentése metilén-, karbonil- vagytiokarbonilcsoport; R1 hidrogén-, halogénatom, nitro-, ciano-,halogén-alkil-, alkil-, alkenil-, alkoxi-, halogén-alkoxi-, azido-, -(CR8R8)qS(O)tR4, hidroxi-, hidroxi-alkil-, aril-, aril-alkil-, aril-oxi-, aril-alkoxi-, heteroaril-, heteroaril-alkil-, heterociklil-,heterociklil-alkil-, heteroaril-alkil-, heterociklil-, heterociklil-alkil-, heteroaril-alkoxi-, aril-alkenil-, heteroaril-alkenil-,heterociklil-alkenil-, -(CR8R8)qNR4R5, -alkenil-C(O)NR4R5, -(CR8R8)qC(O)NR4R5, -(CR8R8)qC(O)NR4R10, -S(O)3R8, -(CR8R8)qC(O)R11, -alkenil-C(O)R11, -alkenil-C(O)OR11, -C(O)R11, -(CR8R8)qC(O)OR12, -(CR8R8)qOC(O)R11, -(CR8R8)qNR4C(O)R11, -(CR8R8)qC(NR4)NR4R5, -(CR8R8)qNR4C(NR5)R11, -(CR8R8)qNHS(O)2R17 vagy -(CR8R8)qS(O)2NR4R5csoport, vagy két R1 csoport együtt -O-(CH2)s-O- csoportot vagy egyciklusos csoportot képezhet; m értéke 1, 2vagy 3 - és a vegyületekettartalmazó, IL-8a vagy IL-8b receptorhoz kötődő kemokin által mediáltbetegségek kezelésére szolgáló gyógyszerkészítményekre vonatkozik. Ó
HU0001940A 1997-01-23 1998-01-23 Benzisothiazole derivatives, their use and pharmaceutical compositions containing them HUP0001940A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3599097P 1997-01-23 1997-01-23
US4283097P 1997-04-08 1997-04-08

Publications (2)

Publication Number Publication Date
HUP0001940A2 true HUP0001940A2 (hu) 2001-01-29
HUP0001940A3 HUP0001940A3 (en) 2002-09-30

Family

ID=26712686

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0001940A HUP0001940A3 (en) 1997-01-23 1998-01-23 Benzisothiazole derivatives, their use and pharmaceutical compositions containing them

Country Status (20)

Country Link
US (1) US6166055A (hu)
EP (1) EP1005341B1 (hu)
JP (1) JP2002515055A (hu)
KR (1) KR20000070369A (hu)
CN (1) CN1253501A (hu)
AR (1) AR008331A1 (hu)
AT (1) ATE381330T1 (hu)
AU (1) AU729893B2 (hu)
BR (1) BR9807085A (hu)
CA (1) CA2278427A1 (hu)
DE (1) DE69838874T2 (hu)
ES (1) ES2299200T3 (hu)
HU (1) HUP0001940A3 (hu)
IL (1) IL131005A0 (hu)
NO (1) NO313913B1 (hu)
NZ (1) NZ336859A (hu)
PE (1) PE103699A1 (hu)
PL (1) PL334774A1 (hu)
TR (1) TR199901761T2 (hu)
WO (1) WO1998032438A1 (hu)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5929250A (en) * 1997-01-23 1999-07-27 Smithkline Beecham Corporation IL-8 receptor antagonists
AR015426A1 (es) * 1997-09-05 2001-05-02 Smithkline Beecham Corp Compuestos de benzotiazol antagonistas del receptor de il-8, composicion farmaceutica que los contiene, su uso para la manufactura de un medicamento,procedimiento para su preparacion, compuestos intermediarios y procedimiento para su preparacion
AR015425A1 (es) * 1997-09-05 2001-05-02 Smithkline Beecham Corp Compuestos de benzotiazol, composicion farmaceutica que los contiene, su uso en la manufactura de un medicamento, procedimiento para su preparacion,compuestos intermediarios y procedimiento para su preparacion
EP1121360A4 (en) * 1998-10-13 2002-01-23 Smithkline Beecham Corp INTERLEUKIN-8 (IL-8) RECEPTOR ANTAGONISTS
WO2000069435A1 (en) * 1999-05-18 2000-11-23 Smithkline Beecham Corporation Il-8 receptor antagonists
EP1196399A1 (en) * 1999-07-16 2002-04-17 Basf Aktiengesellschaft Process for the preparation of substituted benzisothiazole compounds
US6440993B1 (en) 1999-10-12 2002-08-27 Smithkline Beecham Corporation IL-8 receptor antagonists
PE20011124A1 (es) 2000-03-31 2001-10-28 Upjohn Co Nuevos agentes antibacterianos de benzosultam oxazolidinona
DE10038709A1 (de) 2000-08-09 2002-02-28 Aventis Pharma Gmbh Substituierte und unsubstituierte Benzooxathiazole sowie daraus abgeleitete Verbindungen
GB0403038D0 (en) 2004-02-11 2004-03-17 Novartis Ag Organic compounds
CA2565519A1 (en) 2004-05-12 2005-12-01 Schering Corporation Cxcr1 and cxcr2 chemokine antagonists
PE20081785A1 (es) 2007-02-19 2009-01-12 Novartis Ag Derivados de ciclohexil-amida del acido aril carboxilico
TWI643845B (zh) 2012-05-11 2018-12-11 重植治療公司 隱花色素調節劑之含咔唑磺醯胺類
TWI690521B (zh) 2014-04-07 2020-04-11 美商同步製藥公司 作為隱花色素調節劑之含有咔唑之醯胺類、胺基甲酸酯類及脲類

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09511998A (ja) * 1994-04-15 1997-12-02 グラクソ、ウェルカム、インコーポレーテッド １，４ − ベンゾジアゼピン化合物を用いたコレシストキニンアゴニスト活性の誘導方法
JP3720395B2 (ja) * 1994-09-20 2005-11-24 京都薬品工業株式会社 新規ヘテロ環誘導体、その製造方法およびその医薬用途
IL123939A (en) * 1995-10-05 2001-11-25 Kyoto Pharma Ind The history of the heterocycles and the pharmaceutical preparations containing them
US5929250A (en) * 1997-01-23 1999-07-27 Smithkline Beecham Corporation IL-8 receptor antagonists
AR015426A1 (es) * 1997-09-05 2001-05-02 Smithkline Beecham Corp Compuestos de benzotiazol antagonistas del receptor de il-8, composicion farmaceutica que los contiene, su uso para la manufactura de un medicamento,procedimiento para su preparacion, compuestos intermediarios y procedimiento para su preparacion
AR015425A1 (es) * 1997-09-05 2001-05-02 Smithkline Beecham Corp Compuestos de benzotiazol, composicion farmaceutica que los contiene, su uso en la manufactura de un medicamento, procedimiento para su preparacion,compuestos intermediarios y procedimiento para su preparacion
AU2234199A (en) * 1998-01-16 1999-08-02 Smithkline Beecham Corporation Il-8 receptor antagonists

Also Published As

Publication number Publication date
ATE381330T1 (de) 2008-01-15
KR20000070369A (ko) 2000-11-25
NZ336859A (en) 2001-01-26
CN1253501A (zh) 2000-05-17
DE69838874D1 (de) 2008-01-31
ES2299200T3 (es) 2008-05-16
AU5827898A (en) 1998-08-18
DE69838874T2 (de) 2008-12-04
US6166055A (en) 2000-12-26
NO993585D0 (no) 1999-07-22
BR9807085A (pt) 2000-04-18
EP1005341B1 (en) 2007-12-19
AR008331A1 (es) 1999-12-29
EP1005341A4 (en) 2004-09-08
PL334774A1 (en) 2000-03-13
AU729893B2 (en) 2001-02-15
TR199901761T2 (xx) 1999-10-21
IL131005A0 (en) 2001-01-28
CA2278427A1 (en) 1998-07-30
WO1998032438A1 (en) 1998-07-30
HUP0001940A3 (en) 2002-09-30
NO313913B1 (no) 2002-12-23
PE103699A1 (es) 1999-12-30
JP2002515055A (ja) 2002-05-21
EP1005341A1 (en) 2000-06-07
NO993585L (no) 1999-09-21

Similar Documents

Publication Publication Date Title
HUP0001943A2 (hu) Benzimidazol- és benzotriazol-származékok, alkalmazásuk, eljárás előállításukra és az ezeket tartalmazó gyógyszerkészítmények
HUP0004646A2 (hu) IL-8 receptor antagonista hatású benzizotiazolszármazékok, eljárás előállításukra, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények
HUP0001940A2 (hu) Benzizotiazolszármazékok, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények
HUP0302382A2 (hu) IL-8 receptor antagonisták és ezeket tartalmazó gyógyszerkészítmények
BR0014679A (pt) 2-tio-3,5-diciano-4-aril-6-aminopiridinas substituìdas e sua aplicação
AR035735A1 (es) Composicion farmaceutica que se puede administrar por via oral, y el uso de la misma en la fabricacion de un medicamento
BR9909565A (pt) Derivados bicìclicos do ácido hidroxâmico
MA29568B1 (fr) Composes d'azaindazole et methodes d'utilisation desdits composes
ATE339187T1 (de) Verwendung von zusammensetzungen mit antiseptika und/oder die wundheilung fördernden wirkstoffen für den tieferen atemwegstrakt
TNSN00104A1 (fr) Derives d'isothiazole nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
HK1090559A1 (en) Immunosuppressant compounds and compositions
MA28111A1 (fr) Derives des
CL2004001074A1 (es) COMPUESTOS DERIVADOS DE INDOL, 2-AMIDO SUSTITUIDOS, INHIBIDORES DEL FACTO Xa, COMPOSICION FARMACEUTICA, PROCEDIMIENTO DE PREPARACION, UTILES PARA PREPARAR UN MEDICAMENTO PARA TRATAR INFARTO DE MIOCARDIO AGUDO, TRASTORNOS CARDIOVASCULARES, APOPLEJIA,
MA30539B1 (fr) Derives de piperazinyle utiles dans le traitement de maladies induites par le recepteur gpr38.
Das et al. Dimeric 3, 5-bis (benzylidene)-4-piperidones: a novel cluster of tumour-selective cytotoxins possessing multidrug-resistant properties
FR2836917B1 (fr) Derives nitroso de la diphenylamine, compositions pharmaceutiques les contenant en tant que medicaments utilisables dans le traitement des pathologies caracterisees par une situation de stress oxydatif
BRPI0114344B8 (pt) composto retinóide, seu uso, sua composição farmacêutica e seu processo de preparação
HUP0003581A2 (hu) IL-8 receptor antagonista hatású benzizotiazolszármazékok, eljárás előállításukra, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények
BR9914929A (pt) Fenil - alquenoil - guanidinas substituìdas de ácido biliar, processos para a sua preparação, sua aplicação como medicamentos ou agentes diagnósticos, assim como medicamento contendo as mesmas
DE60225195D1 (de) Flavaxat-derivate als muscarin-rezeptor antagonisten
HUP0302614A2 (hu) IL-8 receptor antagonisták és ezeket tartalmazó gyógyszerkészítmények
DE69714735T2 (de) Colchicin-skelett verbindungen, ihre verwendung als arzneimittel und diese verbindungen enthaltende zusammensetzungen
FR2399429A1 (fr) Composes tetrahydro-isoquinoleiniques myorelaxants (agents de blocage de la plaque neuro-musculaire) et medicament contenant ces substances
TW200517382A (en) Imidazole derivatives
DE69214113D1 (de) Neue Pyrrolidinderivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees